Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Contemp Clin Trials. 2020 Nov 14;100:106218. doi: 10.1016/j.cct.2020.106218

Table 3.

Phase 1 Study Procedures Overview

Pre-cessation Week Post-cessation Week
−10 – −5 Orientation −4
Start of Tx
−3 −2 −1 0 Quit Day 1 2 3 End of Tx 4 Follow Up
DEMOGRAPHICS / MENTAL HEALTH
Demographics X
MINI Psychotic Disorders, Alcohol, and Substance Use Disorders for DSM-5[77]a X
SMOKING MEASURES
Smoking Use and History X
Brief Wisconsin Inventory of Smoking Dependence Motives[81] X X X X
Wisconsin Smoking Withdrawal Scale[82] X X X X
Self-Efficacy Scale-Smoking X X X X
ALCOHOL USE MEASURES
Alcohol Use Goalsa X X X X
Alcohol Use History X
Patient Health Questionnaire – Alcohol Use X X X X
Penn Alcohol Craving Scale[78] X X X X
Alcohol Abstinence Self Efficacy[79] X X X X
Drinking Motives Questionnaire – Revised[80] X X X X
MINDFULNESS
Five Facet Mindfulness Questionnaire[84] X X X X
Toronto Mindfulness Scale[85] X X X X X X X X X X
AFFECT / DEPRESSION / STRESS
Center for Epidemiological Studies Depression Scale Revised[86] X X X X
Distress Tolerance Scale[87] X X X X
Perceived Stress Scale[88] X X X X
Positive and Negative Affect Scale[89] X X X X X X X X X X
ALCOHOL USE AND SMOKING STATUS / BIOCHEMICAL VERIFICATION
Timeline Followback[75, 76, 92]a X X X X X X X X X X
Carbon Monoxide (CO)a X X X X X X X X X X
Urinalysis hCG, as applicablea X
Urine Cotinine as applicablea X X
Blood Alcohol Content (BAC)a X X X X X X X X X X
FEEDBACK FROM PARTICIPANTS
End of Treatment Feedback Questionnaire X
Working Alliance Inventory – Short Revised Client Version Modified [90] X
Follow-up Questionnairea X

Note. Tx = “Treatment”

a

= procedure modified from Phase 1 to Phase 2 (see text for details)